Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 3, 2008, Pages 312-319

  Justman, Jessica E ^a,m   Hoover, Donald R ^b   Shi, Qiuhu ^c   Tan, Tianren ^d   Anastos, Kathryn ^e   Tien, Phyllis C ^f   Cole, Stephen R ^g,h   Hyman, Charles ⁱ   Karim, Roksana ^j   Weber, Kathleen ^k   Grinspoon, Steven ^l  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d Analytic Solutions LLC   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ STATE UNIVERSITY OF NEW YORK   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k Jr Hospital of Cook County   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m NONE   (United States)

more..

Author keywords

Anthropometrics; HIV; Waist to hip ratio; Women

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CELL COUNT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MONOTHERAPY; PRIORITY JOURNAL; RACE DIFFERENCE; SERODIAGNOSIS; SMOKING; VIRUS LOAD; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WOMEN'S HEALTH; BODY COMPOSITION; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; EDUCATIONAL STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; ANTHROPOMETRY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY COMPOSITION; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; SMOKING; VIRAL LOAD; WAIST-HIP RATIO;

EID: 42449084611     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318162f597     Document Type: Article

References (39)

1. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
2. Palella FJJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
3. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
4. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51-F58.
5. Dube MP, Parker RA, Tebas P, et al. Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS. 2005;19:1807-1818.
6. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15:1389-1398.
7. Bacchetti P, Gripshover B, Grunfeld C, et al. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr. 2005;40:121-131.
8. Lichtenstein KA, Delaney KM, Armon C, et al. Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1 infected patients. J Acquir Immune Defic Syndr. 2003;32:48-56.
9. Palella FJ Jr, Cole SR, Chmiel JS, et al. Anthropometrics and examiner-reported body habitus abnormalities in the Multicenter AIDS Cohort Study. Clin Infect Dis. 2004;38:903-907.
10. Amorosa V, Synnestvedt M, Gross R, et al. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr. 2005;39:557-561.
11. Ogden CLP, Carroll MDM, Curtin LRP, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
12. Brown T, Wang Z, Chu H, et al. Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2006;43:356-362.
13. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843-1848.
14. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med. 2000;160:2117-2128.
15. UNAIDS. Report on the Global AIDS Epidemic. 2006. Available at: http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp. Accessed October 16, 2007.
16. Bacon MC, von Wyl V, Alden C, et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12:1013-1019.
17. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology. 1998;9:117-125.
18. National Center for Health Statistics. The Third National Health and Examination Survey Reference Manuals and Reports. CD-ROM, 2002. Hyattsville: National Center for Health Statistics, 1996.
19. Department of Health and Human Services and the Henry J. Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med. 1998;128:1079-1100.
20. Lewis CE, Jacobs DR Jr, McCreath H, et al. Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol. 2000;151:1172-1181.
21. Sternfeld B, Wang H, Quesenberry CP Jr, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol. 2004;160:912-922.
22. Williamson DF, Kahn HS, Remington PL, et al. The 10-year incidence of overweight and major weight gain in US adults. Arch Intern Med. 1990;150:665-672.
23. Justman JE, Benning L, Danoff A, et al. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2003;32:298-302.
24. Tien PC, Cole SR, Williams CM, et al. Incidence of lipoatrophy and lipohypertrophy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2003;34:461-466.
25. Schwenk A, Kremer G, Cornely O, et al. Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients. Nutrition. 1999;15:453-457.
26. Yanovski JA, Miller KD, Kino T, et al. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab. 1999;84:1925-1931.
27. Brown T, Chu H, Wang Z, et al. Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy. AIDS. 2007;21:1731-1738.
28. Mwamburi DM, Wilson IB, Jacobson DL, et al. Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:167-173.
29. Mallon PW, Miller J, Cooper DA, et al. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS. 2003;17:971-979.
30. Mulligan K, Anastos K, Justman J, et al. Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2005;38:18-22.
31. Kamel EG, McNeill G, Van Wijk MC. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res. 2000;8:36-42.
32. Stewart KJ, DeRegis JR, Turner KL, et al. Usefulness of anthropometrics and dual-energy x-ray absorptiometry for estimating abdominal obesity measured by magnetic resonance imaging in older men and women. J Cardiopulm Rehabil. 2003;23:109-114.
33. Molarius A, Seidell JC, Sans S, et al. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. Int J Obes Relat Metab Disord. 1999;23:116-125.
34. Centers for Disease Control and Prevention. HIV/AIDS among U.S. women: minority and young women at continuing risk. 2002. Available at: http://www.cdc.gov/hiv/pubs/facts/women.pdf05/02. Accessed May 15, 2002.
35. National Center for Health Statistics. National Health Interview Survey: early release of selected estimates. Available at: www.cdc.gov/nchs/data/nhis/ earlyrelease/200612_06.pdf. Accessed December 12, 2006.
36. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379-384.
37. Zhu S, Wang Z, Heshka S, et al. Waist circumference and obesity-associated risk factors among whites in the Third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76:743-749.
38. Dolan SE, Hadigan C, Killilea KM, et al. Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr. 2005;39:44-54.
39. Schambelan M, Benson CA, Carr A, et al. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA Panel. J Acquir Immune Defic Syndr. 2002;31:257-275.